" class="no-js "lang="en-US"> InveniAI - Medtech Alert
Friday, April 12, 2024
InveniAI | Pharmtech Focus


About InveniAI


InveniAI is pioneering AI and machine learning to map and identify breakthrough innovation across industries.

Our platform, AlphaMeld, is an Artificial Intelligence (AI) based system that monitors millions of data points every day to identify signals for breakthrough events and provides a first mover advantage in detecting early signals of innovation. It combines human ingenuity and experience, with ceaseless, comprehensive and efficient machine learning that ensures no data point is missed in the pursuit of Alpha signals.

AlphaMeld monitors developments daily across industries and rank orders them on their breakthrough potential.

Related Story

Sosei Heptares and InveniAI Enter a Multi-target AI-powered and GPCR-focused Drug Discovery Collaboration

July 6 2021

Sosei Group Corporation (“the Company”) (TSE: 4565), the world leader in GPCR-focused structure-based drug design and […]